Σύγκριση μεθόδων
Εξετάστε τις επιλεγμένες μεθόδους δίπλα-δίπλα· οι γραμμές που διαφέρουν επισημαίνονται.
| Patient Health Questionnaire-2× | Τεστ Διαλογής Κατάχρησης Ουσιών× | |
|---|---|---|
| Πεδίο | Υπηρεσίες Υγείας | Υπηρεσίες Υγείας |
| Οικογένεια | Process / pipeline | Process / pipeline |
| Έτος προέλευσης≠ | 2003 | 1982 |
| Δημιουργός≠ | Kurt Kroenke, Robert L. Spitzer, and Janet B. Williams | Harvey A. Skinner |
| Τύπος≠ | Two-item depression screening instrument | Ten-item substance abuse screening instrument |
| Θεμελιώδης πηγή≠ | Kroenke, K., Spitzer, R. L., & Williams, J. B. (2003). The Patient Health Questionnaire-2: validity of a two-item depression screener. Medical Care, 41(11), 1284-1292. DOI ↗ | Skinner, H. A. (1982). The Drug Abuse Screening Test. Addictive Behaviors, 7(4), 363-371. DOI ↗ |
| Εναλλακτικές ονομασίες | PHQ-2, Patient Health Questionnaire | DAST-10, DAST |
| Συναφείς | 3 | 3 |
| Σύνοψη≠ | The Patient Health Questionnaire-2 (PHQ-2) is an ultra-brief, validated two-item screening instrument developed by Kroenke and colleagues in 2003 to identify major depression in primary care and medical populations. The PHQ-2 assesses the two cardinal symptoms of depression (depressed mood and anhedonia) over the past two weeks using a 0-3 frequency scale. It is the shortest validated depression screening tool enabling routine use in time-constrained clinical settings. | The Drug Abuse Screening Test (DAST) is a brief, validated self-report instrument developed by Skinner in 1982 to screen for drug abuse and dependence in medical and psychiatric populations. The 10-item DAST-10 comprises yes/no questions assessing drug use patterns, consequences, and interference with life functioning. It is widely used in primary care, emergency medicine, and substance abuse treatment settings for rapid identification of individuals requiring further substance abuse evaluation. |
| ScholarGateΣύνολο δεδομένων ↗ |
|
|